ABSORB IV RCT

Clinical Area Interventional Cardiology/Investigational Devices
Study Title ABSORB IV RCT
Purpose of Research The purpose of this study is to evaluate the long-term outcomes of the Absorb BVS (Bioresorbable Vascular Scaffold) compared to XIENCE in the treatment of subjects with ischemic heart disease caused by up to three target de novo native coronary artery lesions, with a maximum of two target lesions per epicardial vessel. It is a randomized trial of 3000 subjects at 140 locations.
Participant Description Subjects with ischemic heart disease caused by up to three de novo coronary artery lesions in with a maximum of two target lesions per epicardial vessel.
Principal Investigator James T. Maddux, MD
Study Coordinator Kelli Hoffman, RN
Study Status Follow-up